Ulrich Budde Selected Research

von Willebrand factor drug combination factor VIII

1/2007	Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
6/2004	Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).
4/2002	Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrich Budde Research Topics

Disease

28	Hemorrhage 10/2022 - 04/2002
19	Thrombotic Thrombocytopenic Purpura 01/2021 - 07/2002
16	von Willebrand Diseases (von Willebrand's Disease) 01/2022 - 04/2002
7	Type 3 von Willebrand Disease 01/2022 - 11/2005
7	Type 1 von Willebrand Disease 01/2020 - 01/2007
5	Inflammation (Inflammations) 01/2022 - 01/2008
5	Thrombosis (Thrombus) 12/2018 - 09/2006
4	Aortic Valve Stenosis (Aortic Stenosis) 02/2019 - 12/2008
4	Thrombocytopenia (Thrombopenia) 02/2017 - 01/2004
4	Thrombotic Microangiopathies 12/2016 - 10/2002
4	Hemophilia A (Haemophilia) 03/2013 - 11/2005
3	Sepsis (Septicemia) 12/2022 - 02/2009
3	COVID-19 01/2022 - 01/2021
3	acquired Thrombotic thrombocytopenic purpura 01/2019 - 07/2008
3	Infections 02/2017 - 09/2004
3	Type 2 von Willebrand Disease 01/2013 - 06/2004
2	Septic Shock (Toxic Shock Syndrome) 12/2022 - 01/2020
2	Ischemic Stroke 01/2020 - 01/2018
2	Vascular System Injuries 01/2019 - 04/2014
2	Acute Kidney Injury (Acute Renal Failure) 01/2015 - 09/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2014 - 09/2006
2	Monoclonal Gammopathy of Undetermined Significance 03/2011 - 09/2006
2	Hemolytic Anemia 09/2010 - 09/2004
2	Wounds and Injuries (Trauma) 11/2005 - 06/2004
2	Hemolytic-Uremic Syndrome 09/2004 - 03/2003
2	Evans Syndrome 01/2004 - 03/2003
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2004 - 03/2003
1	Pneumonia (Pneumonitis) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Thromboinflammation 01/2021
1	Epistaxis (Nosebleed) 01/2020
1	Disease Progression 01/2020
1	Menorrhagia 01/2020
1	Hemarthrosis 01/2020
1	Multiple Myeloma 05/2016
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 05/2016
1	Immunoglobulin Light-chain Amyloidosis 05/2016
1	Cerebral Malaria 03/2016
1	Falciparum Malaria (Plasmodium falciparum Malaria) 03/2016
1	Atypical Hemolytic Uremic Syndrome 01/2016
1	Glycogen Storage Disease (Glycogenosis) 12/2015
1	Virus Diseases (Viral Diseases) 12/2015
1	Kidney Diseases (Kidney Disease) 12/2015

Drug/Important Bio-Agent (IBA)

49	von Willebrand FactorIBA 10/2022 - 04/2002
14	thiamine triphosphorate (TTP)IBA 01/2020 - 07/2002
11	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 06/2004
10	AntigensIBA 10/2022 - 06/2004
7	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2022 - 06/2004
7	Metalloproteases (Metalloproteinases)IBA 01/2020 - 07/2006
6	DisintegrinsIBA 01/2020 - 06/2010
6	ThrombospondinsIBA 01/2020 - 06/2010
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2007
5	Hemostatics (Antihemorrhagics)IBA 01/2020 - 04/2002
4	CollagenIBA 01/2021 - 06/2004
4	AutoantibodiesIBA 01/2020 - 03/2011
4	Peptide Hydrolases (Proteases)FDA Link 01/2015 - 07/2002
3	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 10/2020 - 02/2008
3	CoagulantsIBA 01/2020 - 06/2004
3	Glycoproteins (Glycoprotein)IBA 01/2019 - 04/2002
3	Proteins (Proteins, Gene)FDA Link 09/2017 - 11/2005
3	RistocetinIBA 01/2015 - 11/2005
3	ADAMTS13 ProteinIBA 03/2010 - 07/2002
3	von Willebrand factor drug combination factor VIIIIBA 01/2007 - 04/2002
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2022 - 01/2020
2	Epinephrine (Adrenaline)FDA LinkGeneric 10/2022 - 03/2020
2	Fibrinolysin FDA Link 01/2017 - 05/2016
2	AntibodiesIBA 12/2016 - 01/2014
2	Immunoglobulin M (IgM)IBA 05/2016 - 01/2009
2	Immunoglobulin G (IgG)IBA 01/2014 - 09/2006
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014 - 09/2010
2	Biological ProductsIBA 02/2009 - 04/2008
2	Inosine Triphosphate (ITP)IBA 01/2004 - 03/2003
1	Adenosine Diphosphate (ADP)IBA 10/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	CreatinineIBA 01/2020
1	Thrombospondin 1IBA 12/2018
1	Thromboplastin (Tissue Factor)IBA 09/2018
1	C-Reactive ProteinIBA 01/2018
1	symmetric dimethylarginineIBA 01/2018
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Inflammation MediatorsIBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2017
1	ParaproteinsIBA 05/2016
1	Sepharose (Agarose)IBA 05/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	Complement C3cIBA 01/2016
1	Pharmaceutical PreparationsIBA 12/2015

Therapy/Procedure

7	Therapeutics 12/2022 - 04/2011
5	Plasma Exchange 12/2022 - 10/2002
3	Heart-Assist Devices 04/2014 - 04/2008
2	Minor Surgical Procedures (Minor Surgery) 11/2005 - 06/2004
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Ligation 01/2020
1	Tooth Extraction (Tooth Extractions) 01/2020
1	Plasmapheresis 05/2016
1	Prostheses and Implants (Prosthesis) 04/2015